Published in Tremor Other Hyperkinet Mov (N Y) on January 09, 2013
Speech-Language Pathology Evaluation and Management of Hyperkinetic Disorders Affecting Speech and Swallowing Function. Tremor Other Hyperkinet Mov (N Y) (2017) 0.75
Parkinsonism: onset, progression and mortality. Neurology (1967) 36.06
Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale). Am J Prev Med (1994) 18.43
Cumulative illness rating scale. J Am Geriatr Soc (1968) 9.38
Screening for depression in the older adult: criterion validity of the 10-item Center for Epidemiological Studies Depression Scale (CES-D) Arch Intern Med (1999) 6.89
Screening for depression in elderly primary care patients. A comparison of the Center for Epidemiologic Studies-Depression Scale and the Geriatric Depression Scale. Arch Intern Med (1997) 3.77
The Washington Heights-Inwood Genetic Study of Essential Tremor: methodologic issues in essential-tremor research. Neuroepidemiology (1997) 2.96
Essential tremor: clinical correlates in 350 patients. Neurology (1991) 2.89
Dissociating apathy and depression in Parkinson disease. Neurology (2006) 2.31
Reliability between two observers using a protocol for diagnosing essential tremor. Mov Disord (1998) 2.11
Common misdiagnosis of a common neurological disorder: how are we misdiagnosing essential tremor? Arch Neurol (2006) 2.05
Elevated blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentrations in essential tremor. Neurotoxicology (2007) 1.98
Elevation of blood beta-carboline alkaloids in essential tremor. Neurology (2002) 1.88
Essential tremor centralized brain repository: diagnostic validity and clinical characteristics of a highly selected group of essential tremor cases. Mov Disord (2005) 1.84
Clinical expression of essential tremor: effects of gender and age. Mov Disord (1997) 1.57
Does a screening questionnaire for essential tremor agree with the physician's examination? Neurology (1998) 1.43
Quality of life in Essential Tremor Questionnaire (QUEST): development and initial validation. Parkinsonism Relat Disord (2005) 1.16
Clinical characteristics of essential tremor: data from a community-based study. Mov Disord (1998) 1.13
Quality-of-life impact of non-neoplastic voice disorders: a meta-analysis. Ann Otol Rhinol Laryngol (2006) 1.11
Thalamic stimulation for the treatment of midline tremors in essential tremor patients. Neurology (2000) 1.08
Clinical characteristics of essential voice tremor: a study of 34 cases. Laryngoscope (2010) 1.06
Bilateral thalamic deep brain stimulation: midline tremor control. J Neurol Neurosurg Psychiatry (2005) 1.03
Depressive traits in essential tremor: impact on disability, quality of life, and medication adherence. Eur J Neurol (2012) 0.95
Voice handicap index change following treatment of voice disorders. J Voice (2000) 0.94
LSVT LOUD and LSVT BIG: Behavioral Treatment Programs for Speech and Body Movement in Parkinson Disease. Parkinsons Dis (2012) 0.91
Botulinum toxin injections for essential voice tremor. Ann Otol Rhinol Laryngol (2000) 0.90
Essential vocal tremor: clinical characteristics and response to therapy. South Med J (1985) 0.90
Vocal aging and the impact on daily life: a longitudinal study. J Voice (2004) 0.88
The treatment of essential voice tremor with botulinum toxin A: a longitudinal case report. J Voice (2000) 0.87
Apathy in essential tremor, dystonia, and Parkinson's disease: a comparison with normal controls. Mov Disord (2011) 0.85
Impairments of speech fluency in Lewy body spectrum disorder. Brain Lang (2011) 0.85
Methazolamide for essential voice tremor. Neurology (1996) 0.82
Retracted Treatment of articulatory dysfunction in Parkinson's disease using repetitive transcranial magnetic stimulation. Eur J Neurol (2011) 0.78
[Essential tremor of the voice and treatment with gabapentin]. Rev Neurol (2000) 0.77
Estimating annual rate of decline: prospective, longitudinal data on arm tremor severity in two groups of essential tremor cases. J Neurol Neurosurg Psychiatry (2011) 1.48
Sarcolemmal ATP-sensitive K(+) channels control energy expenditure determining body weight. Cell Metab (2010) 1.31
Clinical characterization of human metapneumovirus infection among patients with cancer. J Infect (2008) 0.98
Blood harmane concentrations in 497 individuals relative to coffee, cigarettes, and food consumption on the morning of testing. J Toxicol (2011) 0.96
Functional correlates of gait and balance difficulty in essential tremor: balance confidence, near misses and falls. Gait Posture (2011) 0.93
Blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentration in essential tremor cases in Spain. Neurotoxicology (2012) 0.92
Development of an essential tremor embarrassment assessment. Parkinsonism Relat Disord (2010) 0.91
Blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentrations in essential tremor: repeat observation in cases and controls in New York. J Toxicol Environ Health A (2012) 0.88
Apathy in essential tremor, dystonia, and Parkinson's disease: a comparison with normal controls. Mov Disord (2011) 0.85
Blood harmane, blood lead, and severity of hand tremor: evidence of additive effects. Neurotoxicology (2010) 0.80
What is the functional significance of nondominant arm tremor in essential tremor? Mov Disord (2010) 0.79
Relationship between blood harmane and harmine concentrations in familial essential tremor, sporadic essential tremor and controls. Neurotoxicology (2010) 0.75
Mental Status Test Scores are Inversely Correlated with Tremor Severity: A Study of 161 Elderly Essential Tremor Cases. Tremor Other Hyperkinet Mov (N Y) (2012) 0.75